Disc Medicine Inc
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
IRON$84.64+4.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Loss
| Year EndedDecember 31, | ||||
|---|---|---|---|---|
| 2024 · · 2023 | ||||
| Operating expenses: · | ||||
| Research and development | $96,671 | | $69,264 | |
| Selling, general and administrative | 33,049 | | 21,861 | |
| Total operating expenses | 129,720 | | 91,125 | |
| Loss from operations | (129,720) | | (91,125) | |
| Other income (expense), net: | | |||
| Interest income | 21,292 | | 14,797 | |
| Interest expense | (572) | — | ||
| Other expense | (2) | | (2) | |
| Total other income (expense), net | 20,718 | | 14,795 | |
| Loss before income taxes | (109,002) | | (76,330) | |
| Income tax expense | (355) | (99) | ||
| Net loss | $(109,357) | | $(76,429) | |
| Net loss per share, basic and diluted | $(3.96) | | $(3.42) | |
| Weighted-average common shares outstanding, basic and diluted | 27,606,022 | 22,315,877 | ||
| Comprehensive loss: | ||||
| Net loss | $(109,357) | $(76,429) | ||
| Other comprehensive income: | ||||
| Foreign currency translation adjustments | (27) | — | ||
| Unrealized gain on marketable securities | 316 | — | ||
| Total other comprehensive income | 289 | — | ||
| Comprehensive loss | $(109,068) | $(76,429) | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.